TO STANDARDIZE THE HAPUSHADI YAPANA BASTI AND STUDY TO KNOW ITS EFFECTIVENESS IN THE MANAGEMENT OF DUCHENNE MUSCULAR DYSTROPHY (DMD)

STANDARDIZATION OF HAPUSHADI YAPANA BASTI AND EVALUATION OF ITS EFFECTIVENESS IN THE MANAGEMENT OF DUCHENNE MUSCULAR DYSTROPHY (DMD) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093505

Enrollment

Registered

2025-08-22

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G710- Muscular dystrophy

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients between age group 5 to 16 years Children having mild to moderate disability Children having DMD or diagnosed nearly on the basis of diagnostic criteria Patients/ guardian willing to sign written consent to participate in the study

Exclusion criteria

Exclusion criteria: Childrens with advanced stage of DMD with cardio myopathies, respiratory complications Congenital muscular dystrophies Congenital Myopathies Metabolic muscle diseases Myelopathies Beckers muscular dystrophy

Design outcomes

Primary

Measure	Time frame
It is expected that at the end of this study we would be able to standardize Hapushadi Yapana Basti with respect to its physicochemical parameters and would be able to demonstrate the effect of Hapushadi Yapana Basti in the management of Duchenne Muscular DystrophyTimepoint: 12 months	—

Secondary

Measure	Time frame
Timepoint: ;NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Antim Bala Gehlot

Pt khushilal sharma ayurveda college and institute Bhopal

umeshayurvedabhopal@gmail.com9425373046

Outcome results